Cleveland, OH, November 4, 2021 – Wave Strategy has appointed six founding members to its Clinical Advisory Board. Members of the Advisory Board bring experience from across many aspects of healthcare and will provide Wave with critical insights as it continues working toward its mission of “Accelerating Innovation in Healthcare.”
Members of the Clinical Advisory Board include:
· Frank Papay, MD – Chairman, Dermatology & Plastic Surgery Institute at Cleveland Clinic
· Michael Vogelbaum, MD, PhD – Program Leader, NeuroOncology at Moffitt Cancer Center
· Rishi Singh, MD – President, Cleveland Clinic Martin North and South Hospitals
· Amresh Raina, MD – Associate Medical Director, Pulmonary Hypertension Program, Allegheny Health Network
· Bela Anand-Apte, MD, PhD, MBA – Chairman, Ophthalmic Research at Cole Eye Institute, Cleveland Clinic
· Ali Khademhosseini, PhD – CEO, Terasaki Institute for Biomedical Innovation
“We are thrilled to have these remarkable leaders join our Clinical Advisory Board. They offer a unique perspective on how to best provide care for patients and also have strong backgrounds in innovation and entrepreneurship,” said Wave Strategy Founder and Managing Partner Neema Mayhugh.
Wave Strategy Partner Matt McBride shared, “Too often we see technologies that are a ‘hammer looking for a nail.’ We believe that every great innovation stems from an underlying unmet need. By including the clinical end-user into the evaluation of early-stage technologies, we are able to get ‘use case’ validation and a sense of the likelihood of adoption.”
